ROSSI JOHN J has a total of 22 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and computer technology are SEQUITUR INC, SYLENTIS SAU and INGENE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 19 | |
#2 | Australia | 1 | |
#3 | Canada | 1 | |
#4 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Computer technology | |
#4 | Organic fine chemistry | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Measuring microorganism processes | |
#5 | Sugars | |
#6 | Bioinformatics | |
#7 | Computational chemistry | |
#8 | Enzymes | |
#9 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Rossi John J | 22 |
#2 | Kim Dongho | 7 |
#3 | Behlke Mark A | 6 |
#4 | Lee Nan-Sook | 4 |
#5 | Yoon Sorah | 3 |
#6 | Zhang Jane | 2 |
#7 | Castanotto Daniela | 2 |
#8 | Zhou Jiehua | 2 |
#9 | Ehsani Ali | 2 |
#10 | Hoehn Britta | 2 |
Publication | Filing date | Title |
---|---|---|
AU2013246419A1 | RNA aptamers for therapeutic and diagnostic delivery to pancreatic cancer cells | |
US2013022538A1 | Aptamer-mRNA conjugates for targeted protein or peptide expression and methods for their use | |
US2008242632A1 | Multi-targeting short interfering RNAs |